Kojc N, Aleš Rigler A, Mlinšek G, Kovač D, Ferluga D, Arnol M.

Outcome of Polyomavirus nephropathy in renal transplant patients – a single center experience.

Clin Nephrol 2017 Supplement 1; 88:109-114.

Arnol M, Oblak M, Mlinšek G, Lindič J, Kandus A, Ferluga D, Kojc N, Buturović-Ponikvar J.

Increase in spot urine protein excretion is associated with late kidney graft rejection and predicts rejection phenotype.

Clin Nephrol 2017 Supplement 1; 88:83-90.

Aleš Rigler A, Jerman A, Orsag A, Kojc N, Kovač D, Škoberne A, Borštnar Š, Večerić Haler Ž, Avguštin N, Kveder R, Ferluga D, Vizjak A, Lindič J.

Rituximab for the treatment of membranous nephropathy: a single-center experience.

Clin Nephrol. 2017 Supplement 1;88(13):27-31.

Avguštin N, Kovač D, Kojc N, Mlinšek G, Lindič J.

Acute granulomatous interstitial nephritis and acute rejection in a kidney transplant recipient after zoledronic acid therapy – a case report and review of the literature.

Clin Nephrol. 2017 Supplement 1;88(13):97-100.

Škoberne A, Borštnar Š, Avguštin N, Kovač D, Rigler AA, Večerić-Haler Ž, Pajek J, Krsnik M, Kojc N, Ferluga D, Lindič J.

Tubular urinary indexes reliably distinguish between primary tubulointerstitial and primary glomerular diseases in patients referred for kidney biopsy. Clin Nephrol.

2017 Supplement 1;88(13):1-6

Oblak T, Lindič J, Gubenšek J, Kveder R, Aleš Rigler A, Škoberne A, Večerić Haler Ž, Borštnar Š, Avguštin N, Ponikvar R, Mlinšek G, Ferluga D, Kojc N, Godnov U, Kovač D.

Treatment of antibody-mediated rejection of kidney grafts with bortezomib and/or rituximab compared to standard regimen: experience of Slovene National Center.

Clin Nephrol. 2017 Supplement 1; 88(13):91-96.